Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Amitriptyline/apixaban overdose

Amitriptyline/apixaban overdose Reactions 1704, p30 - 2 Jun 2018 O S Various toxicities: case report A 48-year-old woman developed unresponsive, anti- cholinergic symptoms and macroscopic haematuria following an overdose of apixaban. Additionally, she also developed decreasing gastrointestinal motility, that resulted in requirement of longer time to normalise her coagulation tests secondary to amitriptyline poisoning, possibly due to overdose [not all durations of treatment to reaction onsets not stated]. The woman, who had hypertension, hypothyroidism and depression, ingested apixaban 210mg and amitriptyline unknown amount, at most 2.5g [exact dosage not stated] along with levothyroxine-sodium [levothyroxine]. Approximately 13h later, she was found unresponsive on her kitchen floor. Two months before, she was prescribed apixaban for bilateral pulmonary embolism. She was admitted to a high dependency unit following her unresponsiveness. She developed anti- cholinergic symptoms and mild transient macroscopic haematuria. Later, she was discharged from the hospital without any major bleeding. However, her coagulation tests took longer time to normalise due to associated amitriptyline poisoning, possibly due to overdose which decreased her gastrointestinal motility [not all outcomes stated]. Author comment: "We present a case that together with Leikin et al.’s report sheds light on the pharmacokinetics of massive apixaban overdose." "Our patient’s coagulation tests http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Amitriptyline/apixaban overdose

Reactions Weekly , Volume 1704 (1) – Jun 2, 2018

Amitriptyline/apixaban overdose

Abstract

Reactions 1704, p30 - 2 Jun 2018 O S Various toxicities: case report A 48-year-old woman developed unresponsive, anti- cholinergic symptoms and macroscopic haematuria following an overdose of apixaban. Additionally, she also developed decreasing gastrointestinal motility, that resulted in requirement of longer time to normalise her coagulation tests secondary to amitriptyline poisoning, possibly due to overdose [not all durations of treatment to reaction onsets not stated]. The woman, who had...
Loading next page...
 
/lp/springer_journal/amitriptyline-apixaban-overdose-rhqSEZFsdL

References (1)

Publisher
Springer Journals
Copyright
Copyright © 2018 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
DOI
10.1007/s40278-018-46673-5
Publisher site
See Article on Publisher Site

Abstract

Reactions 1704, p30 - 2 Jun 2018 O S Various toxicities: case report A 48-year-old woman developed unresponsive, anti- cholinergic symptoms and macroscopic haematuria following an overdose of apixaban. Additionally, she also developed decreasing gastrointestinal motility, that resulted in requirement of longer time to normalise her coagulation tests secondary to amitriptyline poisoning, possibly due to overdose [not all durations of treatment to reaction onsets not stated]. The woman, who had hypertension, hypothyroidism and depression, ingested apixaban 210mg and amitriptyline unknown amount, at most 2.5g [exact dosage not stated] along with levothyroxine-sodium [levothyroxine]. Approximately 13h later, she was found unresponsive on her kitchen floor. Two months before, she was prescribed apixaban for bilateral pulmonary embolism. She was admitted to a high dependency unit following her unresponsiveness. She developed anti- cholinergic symptoms and mild transient macroscopic haematuria. Later, she was discharged from the hospital without any major bleeding. However, her coagulation tests took longer time to normalise due to associated amitriptyline poisoning, possibly due to overdose which decreased her gastrointestinal motility [not all outcomes stated]. Author comment: "We present a case that together with Leikin et al.’s report sheds light on the pharmacokinetics of massive apixaban overdose." "Our patient’s coagulation tests

Journal

Reactions WeeklySpringer Journals

Published: Jun 2, 2018

There are no references for this article.